컨텐츠 바로가기

About iNtRON

㈜인트론바이오는 바이오신약 ‘R&BD 방향’을
‘사람대상’, ‘질병치료제’, ‘First-in-Class (MOA based)’로
설정하고 있으며, 이러한 방향을 지켜나가는 한,
“글로벌 R&D 그룹”으로서, 폭넓고, 자유롭게,
그리고 열정적으로 사업을 영위해 나갈 것입니다!
MORE

논문발표 현황

  • “Fluorescent labeling of cell-free synthesized proteins with fluorophore-conjugated methionylated tRNA derived from in vitro transcribed tRNA” J. Microbiol. Methods 73, 247-251, 2008

  • “Continuous-exchange cell-free protein synthesis using PCR-generated DNA and an RNase E-deficient extract” BioTechniques 44, 387-391, 2008

  • “Rapid activation of CLOCK by Ca2+-dependent PKC mediates resetting of the mammalian circadian clock” EMBO Reports 8, 366-371, 2007

  • “Fluorescent labeling of cell-free synthesized proteins by incorporation of fluorophore-conjugated nonnatural amino acids” Anal. Biochem. 360, 1-6, 2007

  • “Presence of human mycoplasma DNA in gastric tissue samples from Korean chronic gastritis patients” Cancer Science 95, 311-315, 2004

  • “Molecular epidemiology of Newcastle disease in Republic of Korea” Vet. Microbiol. 95, 39-48, 2003

  • “Distribution and characterization of class I integrons in Salmonella enterica serotype Gallinarum biotype Gallinarum” Vet. Microbiol. 89, 303-309, 2002